Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report: “Egypt Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on the analysis of the healthcare, regulatory and reimbursement landscape in Egypt. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Egypt is a large and growing pharmaceutical market in the Middle East with a significant historical, geographic, and political leadership position among Arab states. The Egyptian pharmaceutical industry is growing as a result of the country's large population, shifting demographics, and high disease rates, but it still faces several challenges including high operating costs, government control of drug prices, the dominance of private multinationals on the market, and the devaluation of the Egyptian pound (EGP). In terms of US dollars, the Egyptian pharmaceutical market was forecast to decrease from $4.3billion in 2014 to $3.3billion in 2021, at a negative CAGR of 3.5%. However, in terms of EGP, the Egyptian pharmaceutical market was forecast to increase from EGP30.4billion in 2014 to EGP52.1billion in 2021, at a CAGR of 8.0%. This difference was due to the currency fluctuation between the US Dollar and the Egyptian Pound. In 2016, the medical devices market in Egypt was worth $3.3billion, which increased at a CAGR of 3.9% to $4.0billion in 2021. Egypt’s medical device market is the second largest in the Middle East and North Africa (MENA) region. The production of medical devices in Egypt is very low; most medical devices are supplied from imports. On April 01, 2021, Gypto Pharma City, one of the largest pharmaceutical cities in the Middle East, was founded in Greater Cairo to promote government and private sector partnerships and become a regional hub for pharmaceutical manufacturing in the Middle East. It increases good manufacturing standards, adopts global quality standards, and promotes a competent, tech-savvy workforce.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Egypt, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Pfizer, Novartis, GSK, Sanofi, and EIPICO.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Fresenius, Philips, Amplifon, and Amecath.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in the healthcare market, Healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies, and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure, and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in Egypt’s healthcare market.

• Develop business strategies by understanding the trends shaping and driving the Egyptian healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the Egypt healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership